Poseida Therapeutics Inc.

$PSTX is up over 200% after its partner Roche has agreed to acquire the company for upwards of $1.5 billion

Share this article:

About the Author:

Poseida Therapeutics Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup